Leonard M. Klein

1.9k total citations
49 papers, 834 citations indexed

About

Leonard M. Klein is a scholar working on Oncology, Genetics and Hematology. According to data from OpenAlex, Leonard M. Klein has authored 49 papers receiving a total of 834 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 19 papers in Genetics and 18 papers in Hematology. Recurrent topics in Leonard M. Klein's work include Chronic Lymphocytic Leukemia Research (19 papers), Lymphoma Diagnosis and Treatment (13 papers) and Multiple Myeloma Research and Treatments (11 papers). Leonard M. Klein is often cited by papers focused on Chronic Lymphocytic Leukemia Research (19 papers), Lymphoma Diagnosis and Treatment (13 papers) and Multiple Myeloma Research and Treatments (11 papers). Leonard M. Klein collaborates with scholars based in United States, Canada and France. Leonard M. Klein's co-authors include Kathryn S. Kolibaba, Jeff P. Sharman, Cary A. Presant, Michael Boxer, Jing Hu, Michael Hawkins, Steve Abella, Craig H. Reynolds, Paul Conkling and James F. Fitzgibbons and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Leonard M. Klein

43 papers receiving 802 citations

Peers

Leonard M. Klein

ONCOL

GENET

PFM

HEMAT

Nora Viniou Greece

Eric Raefsky United States

Igor Aurer Croatia

H.‐G. Mergenthaler Germany

ML Hansmann Germany

José C. Cruz United States

C Gisselbrecht France

Lyndah Dreiling United States

Gareth P. Gregory Australia

Martin D. Phillips United States

Nora Viniou Greece

Leonard M. Klein

489 ×1.1

ONCOL

321 ×1.4

GENET

188 ×0.8

PFM

339 ×1.5

546 ×2.7

HEMAT

Citations per year, relative to Leonard M. Klein Leonard M. Klein (= 1×) peers Nora Viniou

Countries citing papers authored by Leonard M. Klein

Since Specialization

Citations

This map shows the geographic impact of Leonard M. Klein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leonard M. Klein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leonard M. Klein more than expected).

Fields of papers citing papers by Leonard M. Klein

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Leonard M. Klein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leonard M. Klein. The network helps show where Leonard M. Klein may publish in the future.

Co-authorship network of co-authors of Leonard M. Klein

This figure shows the co-authorship network connecting the top 25 collaborators of Leonard M. Klein. A scholar is included among the top collaborators of Leonard M. Klein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leonard M. Klein. Leonard M. Klein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rodriguez, Tulio E., et al.. (2023). Long Term Disease Free Survival and Survival of Patients with Relapsed Hodgkin's Lymphoma Treated with Autologous Stem Cell Transplantation. Blood. 142(Supplement 1). 7078–7078.

Dièras, Véronique, Robert Weaver, Sara M. Tolaney, et al.. (2021). Abstract PD13-07: Subgroup analysis of patients with brain metastases from the phase 3 ASCENT study of sacituzumab govitecan versus chemotherapy in metastatic triple-negative breast cancer. Cancer Research. 81(4_Supplement). PD13–7. 47 indexed citations

Klein, Leonard M., et al.. (2020). Primary Gastric Choriocarcinoma: A Case Report of Early Successful Treatment Outcome. JCO Oncology Practice. 16(9). 608–610. 1 indexed citations

Sirota, Ronald L., et al.. (2018). Acute myeloid leukemia with t(4;12)(q12;p13) treated with an allogeneic stem cell transplant: A case report and review of the literature. Leukemia Research Reports. 9. 76–78.

Sharman, Jeff P., Charles M. Farber, Daruka Mahadevan, et al.. (2016). Ublituximab ( TG ‐1101), a novel glycoengineered anti‐ CD 20 antibody, in combination with ibrutinib is safe and highly active in patients with relapsed and/or refractory chronic lymphocytic leukaemia: results of a phase 2 trial. British Journal of Haematology. 176(3). 412–420. 44 indexed citations

Sharman, Jeff P., Charles M. Farber, Daruka Mahadevan, et al.. (2014). Ublituximab (TG-1101), a Novel Glycoengineered Anti-CD20 Monoclonal Antibody, in Combination with Ibrutinib Is Highly Active in Patients with Relapsed and/or Refractory CLL and MCL; Results of a Phase II Trial. Blood. 124(21). 4679–4679. 13 indexed citations

Dalal, Neil, et al.. (2014). Single Donor Versus Acrodose Platelets in Oncology Patients: A Single Institutional Experience. Blood. 124(21). 4298–4298. 2 indexed citations

Berenson, James R., Leonard M. Klein, Robert M. Rifkin, et al.. (2014). Results of the dose-escalation portion of a phase 1/2 study (CHAMPION-1) investigating weekly carfilzomib in combination with dexamethasone for patients with relapsed or refractory multiple myeloma.. Journal of Clinical Oncology. 32(15_suppl). 8594–8594. 6 indexed citations

Hilger, James, James R. Berenson, Leonard M. Klein, et al.. (2013). A phase I/II study (NCT01541332) of pomalidomide (POM), dexamethasone (DEX), and pegylated liposomal doxorubicin (PLD) for patients with relapsed/refractory (R/R) multiple myeloma (MM).. Journal of Clinical Oncology. 31(15_suppl). 8598–8598. 3 indexed citations

10.

Jotte, Robert M., Paul Conkling, Craig H. Reynolds, et al.. (2010). Randomized Phase II Trial of Single-Agent Amrubicin or Topotecan as Second-Line Treatment in Patients With Small-Cell Lung Cancer Sensitive to First-Line Platinum-Based Chemotherapy. Journal of Clinical Oncology. 29(3). 287–293. 128 indexed citations

11.

Micallef, Ivana N., et al.. (2010). Plerixafor (Mozobil) for stem cell mobilization in patients with multiple myeloma previously treated with lenalidomide. Bone Marrow Transplantation. 46(3). 350–355. 42 indexed citations

12.

Bitran, Jacob D., et al.. (2003). High-dose myeloablative therapy and autologous peripheral blood progenitor cell transplantation for elderly patients (greater than 65 years of age) with relapsed large cell lymphoma. Biology of Blood and Marrow Transplantation. 9(6). 383–388. 19 indexed citations

13.

Hakimian, David, Daina Variakojis, Leonard M. Klein, et al.. (1998). Long term follow‐up and late complications of 2‐chlorodeoxyadenosine in previously treated, advanced, indolent non‐hodgkin's lymphoma. Cancer. 82(5). 957–964. 2 indexed citations

14.

Huang, Cheng-Fang, David Hakimian, Daina Variakojis, et al.. (1998). Long term follow-up and late complications of 2-chlorodeoxyadenosine in previously treated, advanced, indolent non-hodgkin's lymphoma. Cancer. 82(5). 957–964. 26 indexed citations

15.

Bitran, Jacob D., et al.. (1996). Her2/neu overexpression is associated with treatment failure in women with high-risk stage II and stage IIIA breast cancer (>10 involved lymph nodes) treated with high-dose chemotherapy and autologous hematopoietic progenitor cell support following standard-dose adjuvant chemotherapy.. PubMed. 2(9). 1509–13. 43 indexed citations

16.

Jd, Bitran, Brian L. Samuels, Leonard M. Klein, et al.. (1996). Tandem high-dose chemotherapy supported by hematopoietic progenitor cells yields prolonged survival in stage IV breast cancer.. PubMed. 17(2). 157–62. 55 indexed citations

17.

Klein, Leonard M., et al.. (1983). Thymidine and 5-FU: a Phase II pilot study in colorectal and breast carcinomas.. PubMed. 67(7-8). 735–6. 4 indexed citations

18.

Shively, John E., et al.. (1982). Serum levels of carcinoembryonic antigen and a tumor-extracted carcinoembryonic antigen-related antigen in cancer patients.. PubMed. 42(6). 2506–13. 15 indexed citations

19.

Klein, Leonard M., et al.. (1961). Seed losses in harvesting some grass and legume crops in the Willamette Valley, Oregon, 1953-1954 /. Biodiversity Heritage Library (Smithsonian Institution). 1 indexed citations

20.

Klein, Leonard M., et al.. (1961). Equipment for cleaning seeds.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact